SEC CIK 1102444
BIOTECHNOLOGY VALUE FUND II LP
Reported ownership across 10 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| CRISview stock → | 7,692,716 | 2009-04-27 |
| CYTKview stock → | 3,811,271 | 2020-12-09 |
| NBIXview stock → | 3,527,700 | 2011-10-12 |
| RGENview stock → | 2,765,050 | 2009-07-07 |
| CTMXview stock → | 2,164,406 | 2020-12-18 |
| VSTMview stock → | 994,353 | 2022-01-25 |
| RIGLview stock → | 646,559 | 2013-11-19 |
| LGNDview stock → | 230,125 | 2014-03-25 |
| XENEview stock → | 216,694 | 2018-03-27 |
| CBIOview stock → | 62,383 | 2025-06-13 |
Position History — CBIO
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — CBIO
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2025-06-13 | J (derivative) | 25,944 | — | 25,944 |
| 2025-06-13 | J (derivative) | 257,515 | — | 257,515 |
| 2025-06-13 | J (derivative) | 304,098 | — | 304,098 |
| 2025-06-13 | J | 56,079 | — | 62,383 |
| 2025-06-13 | J | 556,617 | — | 593,740 |
| 2025-06-13 | J | 657,308 | — | 707,116 |
| 2020-11-04 | Open-market buy | 674,492 | $2.60 | 4,980,812 |
| 2020-11-04 | Open-market buy | 86,090 | $2.60 | 630,453 |
| 2020-11-04 | Open-market buy | 506,155 | $2.60 | 3,712,350 |
| 2020-10-30 | Open-market buy | 666,385 | $2.75 | 4,306,320 |
| 2020-10-30 | Open-market buy | 250,755 | $2.75 | 3,206,195 |
| 2020-10-30 | Open-market buy | 15,472 | $2.75 | 544,363 |
| 2019-09-05 | Open-market buy | 689,834 | $3.18 | 2,955,440 |
| 2019-09-05 | Open-market buy | 124,956 | $3.18 | 528,891 |
| 2019-09-05 | Open-market buy | 853,956 | $3.18 | 3,639,935 |
| 2019-08-15 | — | — | — | 2,265,606 |
| 2019-08-15 | — | — | — | 403,935 |
| 2019-08-15 | — | — | — | 2,785,979 |
| 2017-05-01 | — | — | — | 1,644,624 |
| 2017-05-01 | — | — | — | 298,337 |
| 2017-05-01 | — | — | — | 1,077,703 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.